Copyright
©The Author(s) 2023.
World J Crit Care Med. Sep 9, 2023; 12(4): 188-203
Published online Sep 9, 2023. doi: 10.5492/wjccm.v12.i4.188
Published online Sep 9, 2023. doi: 10.5492/wjccm.v12.i4.188
Ref. | Study characteristics | Results and inference | ||||
Study type | Patient characteristics | Variables | AUC/95%CI | Sensitivity/specificity/PPV/NPV | Inference | |
Tan et al[5], 2019 | Meta-Analysis; 9 studies | Pooled data. Total: 1368 patients. Sepsis: 495. Non sepsis: 873 | CRP; PCT | 0.73 (95%CI: 0.69-0.77), 0.85 (95% CI: 0.82-0.88) | Sensitivity 0.80 (95%CI: 0.63-0.90); spec: 0.61 (95%CI: 0.50-0.72) DOR: 6.89 (95%CI: 3.86-12.31); sensitivity 0.80 (95%CI: 0.69-0.87); specificity: 0.77 (95%CI: 0.60-0.88) DOR: 12.50 (95%CI: 3.65-42.80) | Diagnosis accuracy and specificity of PCT are higher than those of CRP |
Thomas-Rüddel et al[9], 2018 | Randomised control trial, Prospective, Secondary analysis | Gram negative vs Gram positive bacteremia and candidemia | PCT (Gram negative bacteremia) | 0.72 (95%CI: 0.71-0.74) | Value was 10 ng/mL sensitivity 69%, specificity 35% for Gram negative bacteraemia | Streptococci, E. coli and other Enterobacteriaceae detected from BC were associated with three times higher PCT values. Urogenital or abdominal foci of infection were associated with twofold increased PCT |
Lai et al[7], 2020 | Meta-Analysis; 25 studies | GNBSI | CRP | 0.85 (0.81–0.87) | Sens: 0.75 (0.56–0.87); Spec: 0.80 (0.68–0.88) | PCT was helpful in recognizing GNBSI, but the test results should be interpreted carefully with knowledge of patients' medical condition and should not serve as the only criterion for GNBSI |
PCT | 0.87 (0.84–0.90) | Sens: 0.80 (0.60–0.91); Spec: 0.82 (0.72–0.89) | ||||
IL6 | 0.83 (0.80-0.86) | Sens: 0.76 (0.58–0.88); Spec: 0.79 (0.71-0.85) | ||||
Zhao et al[29], 2014 | Prospective; Observational, single centre | Total: 652; Sepsis: 452; Non sepsis SIRS: 200 | PCT | 0.803 | Sens: 75.2%, Spec: 80.0%, PPV: 89.5%, NPV: 58.8% | Combination of PCT, IL6 and D-dimer enhances the diagnostic ability for sepsis and severe sepsis |
IL6 | 0.770 | Sens: 81.0%, Spec: 61.0%, PPV: 82.4%, NPV: 58.7% | ||||
D-Dimer | (0.737) | Sens: 79.9%, Spec: 59.0%, PPV: 81.5%, NPV: 56.5% | ||||
PCT + IL6 + D-Dimer | 0.866 | Sens: 81.6%, Spec: 73.6%, PPV: 56.0%, NPV: 90.6% | ||||
Kondo et al[14], 2019 | Meta-Analysis; 19 studies | Adult. Tot: 3012 | Presepsin | 0.87 | Sens: 0.84 (95% 0.80-0.88); Spec: 0.73 (0.61-0.82) | Diagnostic accuracy of procalcitonin and presepsin in detecting infection was similar |
PCT | 0.84 | Sens: 0.80 (0.75-0.84); spec 0.75 (0.67-0.81) | ||||
Kang et al[16], 2019 | Adult | Infected trauma: 89; Non infected trauma: 68; Healthy controls: 60 | Presepsin | 0.853 (0.784-0.922) | 321.5 pg/mL; Sens: 67.2%; Spec: 91.9; PPV: 87.5; NPV: 78.2; LR+: 4.89; LR-: 0.39 | Presepsin might be a superior biomarker for early differentiation of infection in trauma patients |
PCT | 0.771 (0.682-0.859) | 0.923 ng/mL; Sens: 61.1%; Spec: 88.2%; PPV: 79.1; NPV: 74.7; LR+: 5.21; LR-: 0.47 | ||||
Presepsin + ISS | 0.939 (0.9-0.977) | |||||
Liu et al[15], 2013 | Prospective, adult consecutive, emergency department | Total: 859; Control: 100; SIRS: 372; Sepsis: 372; Severe sepsis: 210; Septic shock: 98 | Presepsin | 0.820 (0.784-0.856) | 317 pg/mL; Sens: 70.8%; Spec: 85.8%; PPV: 93.2%; NPV: 51.6%; LR+: 4.99; LR-: 0.34 | Presepsin is a valuable biomarker for early diagnosis of sepsis. trauma stress elevates PCT, CRP, and WBCs even in the absence of infection |
PCT | 0.724 (0.680 to 0.769) | 0.25 ng/mL; Sens: 60%; Spec: 77.7%; PPV: 93.2%; NPV: 28.4%; LR+: 2.69; LR-: 0.51 | ||||
Cong et al[20], 2021 | Meta-Analysis | Adult 20 studies | CD 64 | 0.94 (0.91-0.96) | Sens: 0.88 (0.81-0.92); Spec: 0.88 (0.83-0.91); LR+: 7.2; LR-: 0.14; DOR-51 (25-101) | Neutrophil CD64 test has a high sensitivity and specificity in adult sepsis patients, and was superior to the traditional biomarkers PCT and IL6 |
PCT | 0.87 (0.83-0.89) | Sens: 0.82 (0.78-0.85); Spec-: 0.78 (0.74-0.82); LR+: 3.7; LR-: 0.23; DOR-16 (11-23) | ||||
IL6 | 0.77 (0.73-0.80) | Sens: 0.72 (0.65-0.78); Spec: 0.70 (0.62-0.76); LR+: 2.4; LR-: 0.40; DOR-6 (4-9) | ||||
Gámez-Díaz et al[25], 2011 | Prospective, cohort | Emergency, total 631 pts; based on expert consensus, Sepsis- 416 | nCD-64 | NA | Sens: 65.8% (95%CI: 61.1%-70.3%); Spec: 64.6% (95%CI: 57.8%-70.8%); LR+: 1.85 (95%CI: 1.52-2.26); LR-: 0.52 (95%CI: 0.44-0.62) | Patients suspected of having any infection in the ED, the accuracy of nCD64, sTREM1, and HMGB-1 was not significantly sensitive or specific for diagnosis of sepsis |
HMGB-1 | Sens: 57.5% (95%CI: 52.7%-62.3%); Spec: 57.8% (95%CI: 51.1%-64.3%); LR+: 1.36 (95%CI: 1.14-1.63); LR-: 0.73 (95%CI: 0.62-0.86) | |||||
s-TREM-1 | Sens: 60% (95%CI: 55.2%-64.7%). Spec: 59.2% (95%CI: 52.5%-65.6%). LR+: 1.47 (95%CI: 1.22-1.76). LR-: 0.67 (95%CI: 0.57-0.79) | |||||
Yeh et al[19], 2019 | Metaanalysis. 14 studies | Adult, pooled data: Total: 2471; Control: 1167; Sepsis: 1304 | Neutrophilic CD 64 | 0.89 (0.87–0.92) | Sens: 0.87 (0.80-0.92); spec 0.89 (0.82-0.93) | Neutrophil CD64 levels are an excellent biomarker with moderate accuracy outperforming both CRP and PCT determinations |
PCT | 0.84 (0.79–0.89) | Sens: 0.76 (0.61-0.86); spec 0.79 (0.70-0.86) | ||||
CRP | 0.84 (0.80–0.88) | Sens: 0.83 (0.78-0.86); spec 0.71 (0.56-0.85) | ||||
Dimoula et al[22], 2014 | Prospective observational study | 548 adult ICU patients. Sepsis: 103; Non sepsis: 445 | nCD64 | NR | 230 MFI. sens: 89% (81%-94%); spec: 87% (83%-90%). | Combining CRP and nCD64 expression, an abnormal result for both was associated with a 92% probability of sepsis, whereas sepsis was ruled out with a probability of 99% if both were normal. In nonseptic patients, an increase in nCD64 expression ≥ 40 MFI predicted ICU-acquired infection (n = 29) with a sensitivity of 88% and specificity of 65% |
Wang et al[23], 2021 | Metaanalysis: 7 articles | Neonatal, paediatric and adults | IL27 | 0.88 (0.84-0.90) | Sens: 0.85 (95%CI: 0.72-0.93); Spec: 0.72 (95%CI: 0.42-0.90); DOR-15 (95%CI: 3-72) | IL27 is a reliable diagnostic biomarker for sepsis and should be evaluated with other clinical tests |
Wong et al[24], 2013 | Prospective | Adults, infective (n = 145) and non-infective (n = 125) critically ill | IL27 | 0.68 (0.62-0.75) | IL27 inferior to PCT in sepsis diagnosis | |
PCT | 0.84 (0.79-0.89) | |||||
Uusitalo-Seppälä et al[27], 2012 | Prospective cohort | 525 adult patients in emergency. Severe sepsis: 49; Sepsis: 302; SIRS: 58. Sirs with no bacterial infection: 53. Bacterial infection no SIRS: 63 | PLA(2)GIIA | NA | OR: 1.48 (1.20-1.81, P < 0.001) | Differences in AUC between these parameters were not significant. On multivariate logistic regression analysis only PLA(2)GIIA could differentiate patients with severe sepsis from others (OR: 1.37, 95%CI: 1.05-1.78, P = 0.019 |
BPI | OR: 2.66 (1.54-4.60, P = 0.001) | |||||
CRP | OR: 1.35 (1.02-1.77, P = 0.036) | |||||
WBC | OR: 2.81 (1.48-5.34, P = 0.002) | |||||
Aksaray et al[26], 2016 | Prospective | ICU, Adult, Sepsis (52), SIRS (38) | STREM1 | 0.78 (0.69–0.86) | sTREM1 cut-off value ≥ 133 pg/mL. Sens: 71.1%; Spec: 67.33%; PPV: 80.43; NPV: 65.91 | sTREM1, APACHES II higher in patients with positive culture than negative cultures. sTREM1, PCT and CRP levels, or WBC count performed equally to differentiate |
PCT | 0.65 (95%CI: 0.53–0.76) | PCT cut-off value of 1.57 ng/mL. Sens: 67.31; Spec: 65.79%; PPV: 72.92; NPV: 70 |
- Citation: Ahuja N, Mishra A, Gupta R, Ray S. Biomarkers in sepsis-looking for the Holy Grail or chasing a mirage! World J Crit Care Med 2023; 12(4): 188-203
- URL: https://www.wjgnet.com/2220-3141/full/v12/i4/188.htm
- DOI: https://dx.doi.org/10.5492/wjccm.v12.i4.188